| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AKYHO
|
1.98 | 499.4M | 12.35 | 0.76 | — | -2.7% | 45.7% | 57 | 32 | 4.46 | +60.1% | 69 | 0.01 |
|
CEOEM
|
23.32 | 1.0B | — | 2.31 | 16.97 | 13.5% | 46.0% | 51 | 41 | 19.07 | -11.7% | 87 | 0.00 |
|
MACKO
|
34.76 | 3.5B | 13.92 | 4.25 | 6.35 | 41.5% | 45.7% | 50 | 38 | 28.69 | -12.6% | 99 | 0.07 |
|
FLAP
|
11.20 | 1.0B | — | 0.98 | — | 0.9% | 45.9% | 49 | 25 | 13.04 | +9.2% | 78 | 0.00 |
|
SNKRN
|
309.75 | 2.4B | 100.00 | 44.78 | 275.34 | 10.6% | 46.0% | 28 | 14 | 77.44 | -56.2% | 80 | 0.08 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.